PAUL KLOTMAN to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications PAUL KLOTMAN has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.836
-
Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. Expert Opin Drug Saf. 2006 Mar; 5(2):275-87.
Score: 0.239
-
Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005 Aug; 16(8):2412-20.
Score: 0.228
-
Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2015 Oct; 30(10):1734-40.
Score: 0.115
-
Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther. 2011; 16(4):591-6.
Score: 0.084
-
HIV-1 and HIV-Associated Nephropathy 25 Years Later. Clin J Am Soc Nephrol. 2007 Jul; 2 Suppl 1:S20-4.
Score: 0.066
-
Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS. 2006 Feb 28; 20(4):561-5.
Score: 0.060
-
HIV type-1 transgene expression in mice alters adipose tissue and adipokine levels: towards a rodent model of HIV type-1 lipodystrophy. Antivir Ther. 2010; 15(7):1021-8.
Score: 0.020
-
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005 Jun 01; 40(11):1559-85.
Score: 0.014
-
Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001 Jun 28; 344(26):1979-84.
Score: 0.011